SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)
CUSIP: 868459108
Q2 2014 13F Holders as of 30 Jun 2014
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,572,193
- Total 13F shares
- 37,124,609
- Share change
- +3,724,331
- Total reported value
- $405,366,758
- Put/Call ratio
- 12%
- Price per share
- $10.95
- Number of holders
- 87
- Value change
- +$42,350,563
- Number of buys
- 52
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 868459108:
Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
18%
|
10,650,000
|
$95,211,000 | — | 31 Mar 2014 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
7.3%
|
4,186,551
|
$37,428,000 | — | 31 Mar 2014 | |
| Abingworth LLP |
13F
|
Company |
6.3%
|
3,600,000
|
$32,148,000 | — | 31 Mar 2014 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.2%
|
1,857,351
|
$16,604,000 | — | 31 Mar 2014 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
2.8%
|
1,590,000
|
$14,215,000 | — | 31 Mar 2014 | |
| Michael R. Murphy |
13F
|
Individual |
2.3%
|
1,345,031
|
$12,025,000 | — | 31 Mar 2014 | |
| NORTHPOINTE CAPITAL LLC |
13F
|
Company |
1.9%
|
1,069,898
|
$9,564,000 | — | 31 Mar 2014 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,052,150
|
$9,406,000 | — | 31 Mar 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.7%
|
975,519
|
$8,721,000 | — | 31 Mar 2014 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1%
|
580,000
|
$5,185,000 | — | 31 Mar 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.92%
|
528,561
|
$4,725,000 | — | 31 Mar 2014 | |
| Orchard Hill Capital Management LP |
13F
|
Company |
0.87%
|
500,754
|
$4,477,000 | — | 31 Mar 2014 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.57%
|
329,801
|
$2,948,000 | — | 31 Mar 2014 | |
| J. Goldman & Co LP |
13F
|
Company |
0.53%
|
306,150
|
$2,737,000 | — | 31 Mar 2014 | |
| MORGAN STANLEY |
13F
|
Company |
0.53%
|
305,877
|
$2,735,000 | — | 31 Mar 2014 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.44%
|
255,028
|
$2,280,000 | — | 31 Mar 2014 | |
| FRANKLIN STREET ADVISORS INC /NC |
13F
|
Company |
0.42%
|
239,900
|
$2,145,000 | — | 31 Mar 2014 | |
| STATE STREET CORP |
13F
|
Company |
0.41%
|
238,836
|
$2,134,000 | — | 31 Mar 2014 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
215,500
|
$1,927,000 | — | 31 Mar 2014 | |
| WHITEBOX ADVISORS LLC |
13F
|
Company |
0.36%
|
206,917
|
$1,850,000 | — | 31 Mar 2014 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
202,868
|
$1,814,000 | — | 31 Mar 2014 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.34%
|
196,537
|
$1,757,000 | — | 31 Mar 2014 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.34%
|
194,071
|
$1,735,000 | — | 31 Mar 2014 | |
| KOPP INVESTMENT ADVISORS LLC |
13F
|
Company |
0.29%
|
165,830
|
$1,483,000 | — | 31 Mar 2014 | |
| Perimeter Capital Partners, LLC |
13F
|
Company |
0.27%
|
156,455
|
$1,399,000 | — | 31 Mar 2014 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.26%
|
152,442
|
$1,363,000 | — | 31 Mar 2014 | |
| REINHART PARTNERS, LLC. |
13F
|
Company |
0.26%
|
152,031
|
$1,359,000 | — | 31 Mar 2014 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.24%
|
140,800
|
$1,259,000 | — | 31 Mar 2014 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.24%
|
138,911
|
$1,242,000 | — | 31 Mar 2014 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.2%
|
115,100
|
$1,029,000 | — | 31 Mar 2014 | |
| Healthcare Value Capital, LLC |
13F
|
Company |
0.19%
|
106,735
|
$954,000 | — | 31 Mar 2014 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.18%
|
104,500
|
$934,000 | — | 31 Mar 2014 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.17%
|
100,000
|
$894,000 | — | 31 Mar 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
85,534
|
$764,000 | — | 31 Mar 2014 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.15%
|
84,720
|
$757,000 | — | 31 Mar 2014 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.14%
|
83,214
|
$744,000 | — | 31 Mar 2014 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
79,926
|
$715,000 | — | 31 Mar 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
77,873
|
$696,000 | — | 31 Mar 2014 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.12%
|
68,149
|
$609,000 | — | 31 Mar 2014 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.09%
|
54,445
|
$487,000 | — | 31 Mar 2014 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.09%
|
53,205
|
$476,000 | — | 31 Mar 2014 | |
| Airain ltd |
13F
|
Company |
0.09%
|
51,395
|
$459,000 | — | 31 Mar 2014 | |
| BOLTON LP |
13F
|
Company |
0.09%
|
50,000
|
$447,000 | — | 31 Mar 2014 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
50,000
|
$447,000 | — | 31 Mar 2014 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
49,300
|
$432,000 | — | 31 Mar 2014 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.08%
|
43,397
|
$387,000 | — | 31 Mar 2014 | |
| ProShare Advisors LLC |
13F
|
Company |
0.07%
|
42,378
|
$379,000 | — | 31 Mar 2014 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.07%
|
39,267
|
$351,000 | — | 31 Mar 2014 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
37,659
|
$337,000 | — | 31 Mar 2014 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.06%
|
36,745
|
$329,000 | — | 31 Mar 2014 |
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2014
As of 30 Jun 2014,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,124,609 shares.
The largest 10 holders included
NEA Management Company, LLC, Abingworth LLP, PRICE T ROWE ASSOCIATES INC /MD/, Murphy Michael R, ARDSLEY ADVISORY PARTNERS, Ameriprise Financial Inc, Consonance Capital Management LP, Orchard Hill Capital Management LP, BlackRock Fund Advisors, and NORTHPOINTE CAPITAL LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2014 vs Q1 2014 Across Filers
Q1 2014 holders
83
Q2 2014 holders
87
Holder diff
4
| Investor | Q1 2014 Shares | Q2 2014 Shares | Share Diff | Share Chg % | Q1 2014 Value $ | Q2 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.